3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Breast Neoplasms
4
Neoplasm Metastasis
3
Lung Neoplasms
3
Triple Negative Breast Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Glioblastoma
2
Colorectal Neoplasms
2
Stroke
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neurologic Manifestations
1
Myelodysplastic Syndromes
1
Motor Activity
1
Melanoma
1
Margins of Excision
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Localized Head and Neck Carcinoma
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Inflammatory Breast Neoplasms
1
Hematologic Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Depression
1
Communication
1
Interventions
cabozantinib
5
Nivolumab
4
Ipilimumab
4
Axitinib
4
pembrolizumab
3
Blood Specimen Collection
3
zimberelimab
2
atezolizumab
2
Surveys and Questionnaires
2
Sunitinib
2
Irinotecan
2
temsirolimus
1
spartalizumab
1
salicylhydroxamic acid
1
palbociclib
1
orellanine
1
olaparib
1
liposomal doxorubicin
1
lenvatinib
1
gallium Ga 68 dotatate
1
fludarabine
1
brodalumab
1
belzutifan
1
aldesleukin
1
adagrasib
1
Vincristine
1
Temozolomide
1
Taxes
1
Selenomethionine
1
Ropivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Palliative Care
×
90 days
×
Clear all
No trials found.